Genetic and epigenetic alterations of BRG1 promote oral cancer development.

Esra Gunduz, Mehmet Gunduz, Mamoru Oouchida, Hitoshi Nagatsuka, Levent Beder, Hidetsugu Tsujigiwa, Kunihiro Fukushima, Kazunori Nishizaki, Kenji Shimizu, Noriyuki Nagai

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

Loss of heterozygosity (LOH) analysis is a sensitive method to detect deletions of specific chromosome regions which are considered to harbor of putative tumor suppressor gene (TSG)s. Previous allelotype analyses in various human cancers suggested the presence of at least one TSG in chromosome 19p13 region. Functional analysis of BRG1, a member of SWI/SNF complex proteins, located at 19p13.2, suggested it to be a candidate TSG in different types of human cancers. We examined LOH at 19p13 region in 39 oral cancers by using six microsatellite markers and found allelic deletion in 25 of 39 (64%) samples. A microsatellite marker near BRG1 locus showed the highest LOH in tumor samples. To clarify the role of BRG1 gene in oral carcinogenesis, we checked its mutation status in tumor samples. As mutation of the BRG1 gene was not detected in oral cancers, we examined the mRNA expression level. Quantitative RT-PCR analysis surprisingly demonstrated increased expression of BRG1 mRNA in 62% of primary tumors as compared with that of matched normal samples. Since functions of BRG1 and BRM, another member of SWI/SNF highly homologous to BRG1, may be interrelated, we also examined BRM mRNA expression in the same samples. In most samples, the expressions of BRG1 and BRM changed in the same direction consistent with reported data on human cancer cell lines. An important finding is that expression of an alternative in frame splicing form of BRG1 which includes exon 26 is selectively decreased or lost in most tumor samples. This unique 33 amino-acid sequence of BRG1 protein shows very high homology with heterogeneous nuclear ribonucleoprotein E and may affect the function and level of BRG1 through modifications on post-transcriptional control. All these findings suggest that the genetic and epigenetic alterations of BRG1 may have a role in oral cancer development.

Original languageEnglish
Pages (from-to)201-210
Number of pages10
JournalInternational Journal of Oncology
Volume26
Issue number1
Publication statusPublished - Jan 2005

Fingerprint

Mouth Neoplasms
Epigenomics
Loss of Heterozygosity
Tumor Suppressor Genes
Neoplasms
Microsatellite Repeats
Messenger RNA
Heterogeneous-Nuclear Ribonucleoproteins
Chromosome Deletion
Mutation
Genes
Amino Acid Sequence
Exons
Carcinogenesis
Proteins
Chromosomes
Cell Line
Polymerase Chain Reaction

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Genetic and epigenetic alterations of BRG1 promote oral cancer development. / Gunduz, Esra; Gunduz, Mehmet; Oouchida, Mamoru; Nagatsuka, Hitoshi; Beder, Levent; Tsujigiwa, Hidetsugu; Fukushima, Kunihiro; Nishizaki, Kazunori; Shimizu, Kenji; Nagai, Noriyuki.

In: International Journal of Oncology, Vol. 26, No. 1, 01.2005, p. 201-210.

Research output: Contribution to journalArticle

Gunduz, E, Gunduz, M, Oouchida, M, Nagatsuka, H, Beder, L, Tsujigiwa, H, Fukushima, K, Nishizaki, K, Shimizu, K & Nagai, N 2005, 'Genetic and epigenetic alterations of BRG1 promote oral cancer development.', International Journal of Oncology, vol. 26, no. 1, pp. 201-210.
Gunduz, Esra ; Gunduz, Mehmet ; Oouchida, Mamoru ; Nagatsuka, Hitoshi ; Beder, Levent ; Tsujigiwa, Hidetsugu ; Fukushima, Kunihiro ; Nishizaki, Kazunori ; Shimizu, Kenji ; Nagai, Noriyuki. / Genetic and epigenetic alterations of BRG1 promote oral cancer development. In: International Journal of Oncology. 2005 ; Vol. 26, No. 1. pp. 201-210.
@article{482504dbe08a4840b21ade077f3a5ac8,
title = "Genetic and epigenetic alterations of BRG1 promote oral cancer development.",
abstract = "Loss of heterozygosity (LOH) analysis is a sensitive method to detect deletions of specific chromosome regions which are considered to harbor of putative tumor suppressor gene (TSG)s. Previous allelotype analyses in various human cancers suggested the presence of at least one TSG in chromosome 19p13 region. Functional analysis of BRG1, a member of SWI/SNF complex proteins, located at 19p13.2, suggested it to be a candidate TSG in different types of human cancers. We examined LOH at 19p13 region in 39 oral cancers by using six microsatellite markers and found allelic deletion in 25 of 39 (64{\%}) samples. A microsatellite marker near BRG1 locus showed the highest LOH in tumor samples. To clarify the role of BRG1 gene in oral carcinogenesis, we checked its mutation status in tumor samples. As mutation of the BRG1 gene was not detected in oral cancers, we examined the mRNA expression level. Quantitative RT-PCR analysis surprisingly demonstrated increased expression of BRG1 mRNA in 62{\%} of primary tumors as compared with that of matched normal samples. Since functions of BRG1 and BRM, another member of SWI/SNF highly homologous to BRG1, may be interrelated, we also examined BRM mRNA expression in the same samples. In most samples, the expressions of BRG1 and BRM changed in the same direction consistent with reported data on human cancer cell lines. An important finding is that expression of an alternative in frame splicing form of BRG1 which includes exon 26 is selectively decreased or lost in most tumor samples. This unique 33 amino-acid sequence of BRG1 protein shows very high homology with heterogeneous nuclear ribonucleoprotein E and may affect the function and level of BRG1 through modifications on post-transcriptional control. All these findings suggest that the genetic and epigenetic alterations of BRG1 may have a role in oral cancer development.",
author = "Esra Gunduz and Mehmet Gunduz and Mamoru Oouchida and Hitoshi Nagatsuka and Levent Beder and Hidetsugu Tsujigiwa and Kunihiro Fukushima and Kazunori Nishizaki and Kenji Shimizu and Noriyuki Nagai",
year = "2005",
month = "1",
language = "English",
volume = "26",
pages = "201--210",
journal = "International Journal of Oncology",
issn = "1019-6439",
publisher = "Spandidos Publications",
number = "1",

}

TY - JOUR

T1 - Genetic and epigenetic alterations of BRG1 promote oral cancer development.

AU - Gunduz, Esra

AU - Gunduz, Mehmet

AU - Oouchida, Mamoru

AU - Nagatsuka, Hitoshi

AU - Beder, Levent

AU - Tsujigiwa, Hidetsugu

AU - Fukushima, Kunihiro

AU - Nishizaki, Kazunori

AU - Shimizu, Kenji

AU - Nagai, Noriyuki

PY - 2005/1

Y1 - 2005/1

N2 - Loss of heterozygosity (LOH) analysis is a sensitive method to detect deletions of specific chromosome regions which are considered to harbor of putative tumor suppressor gene (TSG)s. Previous allelotype analyses in various human cancers suggested the presence of at least one TSG in chromosome 19p13 region. Functional analysis of BRG1, a member of SWI/SNF complex proteins, located at 19p13.2, suggested it to be a candidate TSG in different types of human cancers. We examined LOH at 19p13 region in 39 oral cancers by using six microsatellite markers and found allelic deletion in 25 of 39 (64%) samples. A microsatellite marker near BRG1 locus showed the highest LOH in tumor samples. To clarify the role of BRG1 gene in oral carcinogenesis, we checked its mutation status in tumor samples. As mutation of the BRG1 gene was not detected in oral cancers, we examined the mRNA expression level. Quantitative RT-PCR analysis surprisingly demonstrated increased expression of BRG1 mRNA in 62% of primary tumors as compared with that of matched normal samples. Since functions of BRG1 and BRM, another member of SWI/SNF highly homologous to BRG1, may be interrelated, we also examined BRM mRNA expression in the same samples. In most samples, the expressions of BRG1 and BRM changed in the same direction consistent with reported data on human cancer cell lines. An important finding is that expression of an alternative in frame splicing form of BRG1 which includes exon 26 is selectively decreased or lost in most tumor samples. This unique 33 amino-acid sequence of BRG1 protein shows very high homology with heterogeneous nuclear ribonucleoprotein E and may affect the function and level of BRG1 through modifications on post-transcriptional control. All these findings suggest that the genetic and epigenetic alterations of BRG1 may have a role in oral cancer development.

AB - Loss of heterozygosity (LOH) analysis is a sensitive method to detect deletions of specific chromosome regions which are considered to harbor of putative tumor suppressor gene (TSG)s. Previous allelotype analyses in various human cancers suggested the presence of at least one TSG in chromosome 19p13 region. Functional analysis of BRG1, a member of SWI/SNF complex proteins, located at 19p13.2, suggested it to be a candidate TSG in different types of human cancers. We examined LOH at 19p13 region in 39 oral cancers by using six microsatellite markers and found allelic deletion in 25 of 39 (64%) samples. A microsatellite marker near BRG1 locus showed the highest LOH in tumor samples. To clarify the role of BRG1 gene in oral carcinogenesis, we checked its mutation status in tumor samples. As mutation of the BRG1 gene was not detected in oral cancers, we examined the mRNA expression level. Quantitative RT-PCR analysis surprisingly demonstrated increased expression of BRG1 mRNA in 62% of primary tumors as compared with that of matched normal samples. Since functions of BRG1 and BRM, another member of SWI/SNF highly homologous to BRG1, may be interrelated, we also examined BRM mRNA expression in the same samples. In most samples, the expressions of BRG1 and BRM changed in the same direction consistent with reported data on human cancer cell lines. An important finding is that expression of an alternative in frame splicing form of BRG1 which includes exon 26 is selectively decreased or lost in most tumor samples. This unique 33 amino-acid sequence of BRG1 protein shows very high homology with heterogeneous nuclear ribonucleoprotein E and may affect the function and level of BRG1 through modifications on post-transcriptional control. All these findings suggest that the genetic and epigenetic alterations of BRG1 may have a role in oral cancer development.

UR - http://www.scopus.com/inward/record.url?scp=21644468676&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=21644468676&partnerID=8YFLogxK

M3 - Article

VL - 26

SP - 201

EP - 210

JO - International Journal of Oncology

JF - International Journal of Oncology

SN - 1019-6439

IS - 1

ER -